Skip to content

Clinical trials

Completed Phase 2 Metabolism, Inborn Errors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Phase 2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20091
20111
20141
20151
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
Kastle Therapeutics, LLC2
Masonic Cancer Center, University of Minnesota2
Akcea Therapeutics1
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Children's Hospital Medical Center, Cincinnati1
Fred Hutchinson Cancer Center1
New York Medical College1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors18
Rare Diseases7
Metabolic Diseases6
Genetic Diseases, Inborn5
Lipid Metabolism Disorders4
Lipid Metabolism, Inborn Errors4
Bone Marrow Failure Disorders3
Dyslipidemias3
Hyperlipidemias3
Infant, Newborn, Diseases3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.